Document is current
Any future updates will be listed below
-
Authors
Lääveri, Tinja
Vlot, Jessica A.
van Dam, Alje P.
Häkkinen, Hanni K.
Sonder, Gerard J. B.
Visser, Leo G.
Kantele, Anu http://orcid.org/0000-0002-0004-1000
-
Funding
Funding for this research was provided by:
Finnish government subsidy for health science research (TYH2012141, TYH 2013218 and TYH 2014216)
Paulon Säätiö
SSAC foundation (SLS-504141)
Research and Development fund GGD Amsterdam
ZonMw, the Netherlands Organisation for Health Research and Development (125020011)
European Society of Clinical Microbiology and Infectious Diseases (CH)
Department of Medical Microbiology of the Leiden University Medical Center, the Netherlands.
- License Information
-
More Information
Article History
Received: 20 October 2017
Accepted: 9 July 2018
First Online: 23 July 2018
Ethics approval and consent to participate
: In all studies, written informed consent was obtained from all participants and the Ethics Committees in the respective organisations approved the study protocols. (METc, NL29769.029.09) of the VU University Medical Centre (NTR Trial ID NTR2453); Ethics Committee of the Department of Medicine in Helsinki University Hospital (406/13/03/01/08); Medical Ethics Committee of the Leiden University Medical Center. (P11.036).
: Not applicable
: TL, JV, APvD, HH, GS, LV, declare no competing interests. AK has received honorary for lectures (Pfizer, MSD, Valneva, Immuron) and membership in advisory board (Valneva), and an investigator-initiated grant (Pfizer), none of these relevant to the current manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
